A Study in Patients With Erosive Esophagitis to Investigate Safety, Tolerability, and Healing Rates After 4 Weeks Treatment of X842 or Lansoprazole and Symptom Pattern During Subsequent 4 Weeks Treatment With Lansoprazole

Clinical trial NCT05055128 · COMPLETED

Trial details

NCT number: NCT05055128
Sponsor: Cinclus Pharma Holding AB
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Erosive Esophagitis

Start date: 2021-08-11
Primary completion: 2022-09-01
Enrollment: 248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.